Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 8848 | 4.52 |
09:34 ET | 1378 | 4.549 |
09:36 ET | 627 | 4.5 |
09:39 ET | 100 | 4.53 |
09:41 ET | 782 | 4.55 |
09:43 ET | 546 | 4.58 |
09:45 ET | 1000 | 4.535 |
09:48 ET | 100 | 4.535 |
09:50 ET | 1500 | 4.6 |
09:52 ET | 220 | 4.59 |
09:54 ET | 1774 | 4.52 |
09:56 ET | 756 | 4.47 |
09:57 ET | 3604 | 4.47 |
09:59 ET | 700 | 4.54 |
10:01 ET | 400 | 4.47 |
10:03 ET | 1790 | 4.5099 |
10:06 ET | 400 | 4.51 |
10:08 ET | 900 | 4.52 |
10:12 ET | 713 | 4.53 |
10:14 ET | 300 | 4.55 |
10:17 ET | 330 | 4.51 |
10:19 ET | 500 | 4.51 |
10:21 ET | 100 | 4.54 |
10:24 ET | 148 | 4.53 |
10:26 ET | 400 | 4.54 |
10:28 ET | 500 | 4.54 |
10:30 ET | 1254 | 4.53 |
10:32 ET | 1264 | 4.524 |
10:33 ET | 200 | 4.525 |
10:35 ET | 806 | 4.51 |
10:39 ET | 1200 | 4.5178 |
10:42 ET | 1608 | 4.52 |
10:46 ET | 200 | 4.5113 |
10:48 ET | 300 | 4.53 |
10:50 ET | 513 | 4.53 |
10:53 ET | 1356 | 4.54 |
10:55 ET | 300 | 4.52 |
10:57 ET | 100 | 4.51 |
11:00 ET | 100 | 4.49 |
11:02 ET | 200 | 4.49 |
11:06 ET | 100 | 4.505 |
11:08 ET | 100 | 4.51 |
11:09 ET | 224 | 4.52 |
11:11 ET | 1451 | 4.48 |
11:13 ET | 241 | 4.47 |
11:15 ET | 700 | 4.49 |
11:18 ET | 300 | 4.5 |
11:20 ET | 400 | 4.495 |
11:24 ET | 300 | 4.5 |
11:29 ET | 100 | 4.49 |
11:31 ET | 1100 | 4.4915 |
11:33 ET | 300 | 4.49 |
11:36 ET | 100 | 4.49 |
11:38 ET | 500 | 4.48 |
11:40 ET | 700 | 4.48 |
11:42 ET | 200 | 4.48 |
11:44 ET | 975 | 4.465 |
11:45 ET | 300 | 4.465 |
11:47 ET | 100 | 4.47 |
11:51 ET | 511 | 4.469 |
11:54 ET | 400 | 4.46 |
11:56 ET | 1300 | 4.465 |
11:58 ET | 1165 | 4.475 |
12:00 ET | 100 | 4.475 |
12:02 ET | 100 | 4.475 |
12:03 ET | 600 | 4.48 |
12:05 ET | 200 | 4.475 |
12:07 ET | 2420 | 4.465 |
12:09 ET | 709 | 4.48 |
12:12 ET | 200 | 4.47 |
12:14 ET | 333 | 4.475 |
12:16 ET | 400 | 4.475 |
12:18 ET | 1133 | 4.47 |
12:20 ET | 100 | 4.47 |
12:21 ET | 100 | 4.47 |
12:23 ET | 400 | 4.47 |
12:25 ET | 833 | 4.4626 |
12:27 ET | 100 | 4.465 |
12:30 ET | 1100 | 4.475 |
12:34 ET | 200 | 4.475 |
12:36 ET | 300 | 4.475 |
12:38 ET | 500 | 4.4767 |
12:39 ET | 1860 | 4.455 |
12:41 ET | 300 | 4.45 |
12:43 ET | 500 | 4.455 |
12:45 ET | 1533 | 4.465 |
12:48 ET | 100 | 4.465 |
12:50 ET | 1299 | 4.46 |
12:52 ET | 100 | 4.46 |
12:54 ET | 400 | 4.465 |
12:56 ET | 300 | 4.465 |
12:57 ET | 500 | 4.465 |
12:59 ET | 400 | 4.47 |
01:01 ET | 1866 | 4.464 |
01:03 ET | 788 | 4.46 |
01:06 ET | 2021 | 4.46 |
01:10 ET | 200 | 4.465 |
01:12 ET | 800 | 4.46 |
01:14 ET | 200 | 4.47 |
01:15 ET | 200 | 4.465 |
01:17 ET | 100 | 4.465 |
01:19 ET | 5440 | 4.49 |
01:21 ET | 100 | 4.485 |
01:24 ET | 1137 | 4.475 |
01:26 ET | 1200 | 4.47 |
01:28 ET | 628 | 4.47 |
01:30 ET | 3060 | 4.46 |
01:32 ET | 100 | 4.465 |
01:33 ET | 200 | 4.465 |
01:35 ET | 300 | 4.46 |
01:37 ET | 200 | 4.46 |
01:39 ET | 300 | 4.46 |
01:42 ET | 693 | 4.46 |
01:44 ET | 1409 | 4.47 |
01:46 ET | 100 | 4.46 |
01:48 ET | 500 | 4.47 |
01:50 ET | 100 | 4.47 |
01:51 ET | 1100 | 4.485 |
01:53 ET | 925 | 4.47 |
01:55 ET | 680 | 4.465 |
01:57 ET | 100 | 4.46 |
02:00 ET | 600 | 4.45 |
02:02 ET | 200 | 4.45 |
02:04 ET | 800 | 4.45 |
02:06 ET | 100 | 4.45 |
02:08 ET | 500 | 4.455 |
02:09 ET | 200 | 4.45 |
02:11 ET | 400 | 4.45 |
02:13 ET | 200 | 4.455 |
02:15 ET | 100 | 4.455 |
02:18 ET | 1414 | 4.465 |
02:20 ET | 1121 | 4.46 |
02:22 ET | 200 | 4.46 |
02:24 ET | 200 | 4.46 |
02:26 ET | 1937 | 4.46 |
02:27 ET | 1300 | 4.46 |
02:29 ET | 400 | 4.45 |
02:31 ET | 989 | 4.465 |
02:33 ET | 300 | 4.465 |
02:36 ET | 1351 | 4.475 |
02:38 ET | 818 | 4.475 |
02:40 ET | 1903 | 4.49 |
02:42 ET | 1203 | 4.49 |
02:44 ET | 966 | 4.485 |
02:45 ET | 917 | 4.485 |
02:47 ET | 1180 | 4.485 |
02:49 ET | 2204 | 4.49 |
02:51 ET | 703 | 4.495 |
02:54 ET | 1358 | 4.5 |
02:56 ET | 3748 | 4.475 |
02:58 ET | 900 | 4.47 |
03:00 ET | 6558 | 4.46 |
03:02 ET | 1001 | 4.46 |
03:03 ET | 667 | 4.46 |
03:05 ET | 1094 | 4.45 |
03:07 ET | 600 | 4.45 |
03:09 ET | 1176 | 4.465 |
03:12 ET | 1223 | 4.465 |
03:14 ET | 678 | 4.47 |
03:16 ET | 3381 | 4.47 |
03:18 ET | 1028 | 4.47 |
03:20 ET | 2115 | 4.475 |
03:21 ET | 829 | 4.475 |
03:23 ET | 1631 | 4.49 |
03:25 ET | 7766 | 4.495 |
03:27 ET | 1000 | 4.5 |
03:30 ET | 5551 | 4.49 |
03:32 ET | 1970 | 4.495 |
03:34 ET | 630 | 4.5 |
03:36 ET | 1239 | 4.495 |
03:38 ET | 1109 | 4.495 |
03:39 ET | 2943 | 4.485 |
03:41 ET | 3078 | 4.495 |
03:43 ET | 4868 | 4.5 |
03:45 ET | 3348 | 4.51 |
03:48 ET | 5209 | 4.485 |
03:50 ET | 3752 | 4.49 |
03:52 ET | 42508 | 4.55 |
03:54 ET | 11251 | 4.56 |
03:56 ET | 17070 | 4.53 |
03:57 ET | 7905 | 4.55 |
03:59 ET | 19985 | 4.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 519.9M | -2.4x | --- |
Iteos Therapeutics Inc | 534.6M | -3.9x | --- |
Larimar Therapeutics Inc | 518.7M | -8.4x | --- |
Lyell Immunopharma Inc | 522.6M | -2.3x | --- |
Astria Therapeutics Inc | 517.8M | -4.1x | --- |
Taysha Gene Therapies Inc | 553.6M | -2.5x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $519.9M |
---|---|
Revenue (TTM) | $-477.0K |
Shares Outstanding | 114.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.99 |
EPS | $-1.91 |
Book Value | $-0.20 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.